Testing for human papillomavirus (HPV) relies exclusively on techniques of molecular
biology using nucleic acid probes. Tests for HPV using nucleic acid probes have been …

We compared the results of human papillomavirus (HPV) detection and typing from 781
cervical samples assayed by three methods: L1 consensus PCR followed by cycle …

Amplification of human papillomavirus (HPV) DNA by L1 consensus primer systems (eg,
MY09/11 or GP5+/6+) can detect as few as 10 to 100 molecules of HPV targets from a …

Real-time human papillomavirus (HPV) type-specific multiplex PCR assays were developed
to detect HPV DNA in specimens collected for the efficacy determination of the quadrivalent …

Currently, human papillomavirus (HPV) DNA tests validated in large trials and
epidemiological studies are the hybrid capture second-generation (HC2) HPV DNA assay …

Human papillomaviruses (HPV) cause benign and malignant lesions of the epithelial and
mucosal surfaces. Certain virus types are associated with cervical carcinomas, 1–3 while …

Typing of human papillomaviruses (HPV) by DNA hybridization procedures, such as reverse
line blot (RLB) assay, is sensitive and well validated. However, the application of these …

The unprecedented sensitivity of the polymerase chain reaction (PCR) DNA amplification
technology provides numerous advantages for the detection of human papillomavirus (HPV) …

Human papillomaviruses (HPVs) play an important role in the pathogenesis of cervical
cancer. For identification of the large number of different HPV types found in (pre) malignant …

Background: The establishment of the causal relationship between high-risk human
papillomavirus (HR-HPV) infection and cervical cancer and its precursors has resulted in the …